Triad Wealth Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$890K Sell
2,111
-58
-3% -$23.1K 0.05% 226
2026
Q2
$822K Buy
2,169
+756
+54% +$259K 0.05% 228
2026
Q1
$497K Buy
1,413
+298
+27% +$106K 0.04% 276
2025
Q4
$365K Buy
1,115
+288
+35% +$91.4K 0.03% 340
2025
Q3
$233K Buy
827
+89
+12% +$25.8K 0.03% 335
2025
Q2
$206K Buy
+738
New +$209K 0.04% 284
2024
Q3
– Sell
-410
Closed -$128K – 82
2024
Q2
$128K Buy
+410
New +$120K 0.07% 132

Other funds holding AMGN

Triad Wealth Partners's AMGN Position: Q3 2026 in Review

Triad Wealth Partners reduced its Amgen (AMGN) stake by 2.7% in Q3 2026, selling an estimated $23.1K and leaving 2,111 shares worth $890K. The position accounts for 0.05% of the portfolio, ranked #226.

Triad Wealth Partners first reported a position in AMGN in Q2 2024 and has held it in 7 quarters since. 2,617 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Triad Wealth Partners held 2,111 shares of Amgen worth $890K as of Q3 2026.
  • Triad Wealth Partners sold 58 Amgen shares in Q3 2026, an estimated $23.1K.
  • Amgen made up 0.05% of Triad Wealth Partners's portfolio in Q3 2026, its #226 holding.
  • Triad Wealth Partners first reported a position in Amgen in Q2 2024 and has held it in 7 quarters since.
  • 2,617 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Triad Wealth Partners's 13F filing for Q3 2026, filed 26 Oct 2026.